Report cover image

Middle East Clinical Nutrition Market Size, Share & Trends Analysis Report By Product (Parenteral, Enteral, Oral), By Application (Malabsorption/GI Disorder/Diarrhea, Cancer Care), By Sales Channel (Online, Retail), By Country, And Segment Forecasts, 2025

Publisher Grand View Research
Published Sep 11, 2025
Length 90 Pages
SKU # GV20471026

Description

Middle East Clinical Nutrition Market Summary

The Middle East clinical nutrition market size was estimated at USD 1,235.8 million in 2024 and is projected to reach USD 1,644.1 million by 2033, growing at a CAGR of 3.11% from 2025 to 2033. High prevalence of malnutrition, a rising burden of chronic diseases, expanding healthcare infrastructure, and a growing elderly population are some of the key drivers of this market.

According to the Global Nutrition Report, the UAE faces a major nutrition challenge, with 44.2% of women and 30.9% of men aged 18 and older classified as obese. These rates are not only alarmingly high but also significantly above the regional averages for Western Asia, which are 10.3% for women and 7.5% for men. This gap highlights that obesity has become a widespread public health issue in the UAE. Such a high prevalence points to a form of malnutrition, specifically over nutrition, that requires targeted intervention through structured nutrition strategies. Therefore, there is a growing reliance on clinical nutrition products, such as tailored oral supplements, low-calorie meal replacements, and disease-specific nutrition formulas, to help manage weight, maintain balanced nutrient intake, and support overall nutritional health.

According to the United Arab Emirates’ government portal, as of 2021, 11.8% of the UAE’s population aged 20-79 years was affected by diabetes. Reducing the prevalence of this condition is a key performance indicator under the pillar of world-class healthcare in the UAE National Agenda 2021. To address this challenge, the Ministry of Health and Prevention launched several initiatives, including the Diabetes Screening and Professional Healthcare Education program, which focused on screening 10,000 high-risk individuals and training 90 nurses through the Johnson & Johnson Diabetes Institute (JJDI) curriculum. These national efforts highlight the important role of structured care in managing diabetes, thereby increasing the demand for clinical nutrition solutions, such as specialized dietary formulas and oral nutrition supplements that support better glucose control and dietary management. As diabetes remains a major health challenge, the use of clinical nutrition products continues to grow.

Middle Clinical Nutrition Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East clinical nutrition market report based on product, application, sales channel, and country.
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Oral Clinical Nutrition
  • Parenteral Nutrition
  • Carbohydrates
  • Parenteral Lipid Emulsion
  • Single Dose Amino Acid Solutions
  • Trace Elements
  • Vitamins & Minerals
  • Enteral Feeding Formulas
  • Standard Formula
  • Disease-specific Formulas
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Alzheimer’s
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Pain Management
  • Malabsorption/GI Disorder/Diarrhea
  • Others
  • Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Online Sales Channels
  • Retail Sales Channel
  • Institutional Sales Channel
  • Country Outlook (Revenue, USD Million, 2021 - 2033)
  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar
  • Oman
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

90 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. Sales Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising geriatric population
3.2.1.2. Growing prevalence of chronic diseases
3.2.1.3. Increasing risk of malnutrition
3.2.1.4. Shifting trend toward the consumption of disease-specific formulas
3.2.2. Market Restraint Analysis
3.2.2.1. Lack of awareness in the medical community
3.2.2.2. Improper categorization of clinical nutrition
3.2.3. Industry Opportunity Analysis
3.2.4. Industry Challenge Analysis
3.3. Business Environment Analysis
3.3.1. Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal Landscape
Chapter 4. Middle East Clinical Nutrition Market: Product Estimates & Trend Analysis
4.1. Product Segment Dashboard
4.2. Product Market Share Movement Analysis, 2024 & 2033
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Oral Clinical Nutrition
4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Parenteral Nutrition
4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Carbohydrates
4.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Parenteral Lipid Emulsion
4.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.4. Single Dose Amino Acid Solution
4.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.5. Trace Elements
4.5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.6. Vitamins & Minerals
4.5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Enteral Feeding Formulas
4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.2. Standard Formula
4.6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.3. Disease-Specific Formulas
4.6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Middle East Clinical Nutrition Market: Application Estimates & Trend Analysis
5.1. Application Dashboard
5.2. Application Market Share Movement Analysis, 2024 & 2033
5.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Alzheimer’s
5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Nutrition Deficiency
5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Cancer Care
5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Diabetes
5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Chronic Kidney Diseases
5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.9. Orphan Diseases
5.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.10. Dysphagia
5.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.11. Pain Management
5.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.12. Malabsorption/GI Disorder/Diarrhea
5.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.13. Others
5.13.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Middle East Clinical Nutrition Market: Sales Channel Estimates & Trend Analysis
6.1. Sales Channel Segment Dashboard
6.2. Sales Channel Market Share Movement Analysis, 2024 & 2033
6.3. Market Size & Forecasts and Trend Analysis, by Sales Channel, 2021 to 2033 (USD Million)
6.4. Online Sales Channels
6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Retail Sales Channel
6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Institutional Sales Channel
6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Middle East Clinical Nutrition Market: Country Estimates & Trend Analysis
7.1. Country Market Dashboard
7.2. Country Market: Key Takeaways
7.2.1. Saudi Arabia
7.2.1.1. Key country dynamic
7.2.1.2. Regulatory framework
7.2.1.3. Competitive insights
7.2.1.4. Saudi Arabia Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
7.2.2. UAE
7.2.2.1. Key country dynamic
7.2.2.2. Regulatory framework
7.2.2.3. Competitive insights
7.2.2.4. UAE Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
7.2.3. Kuwait
7.2.3.1. Key country dynamic
7.2.3.2. Regulatory framework
7.2.3.3. Competitive insights
7.2.3.4. Kuwait Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
7.2.4. Qatar
7.2.4.1. Key country dynamic
7.2.4.2. Regulatory framework
7.2.4.3. Competitive insights
7.2.4.4. Qatar Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
7.2.5. Oman
7.2.5.1. Key country dynamic
7.2.5.2. Regulatory framework
7.2.5.3. Competitive insights
7.2.5.4. Oman Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. AbbVie Inc.
8.5.1.1. Overview
8.5.1.2. Financial performance
8.5.1.3. Product benchmarking
8.5.1.4. Strategic initiatives
8.5.2. Grifols, S.A.
8.5.2.1. Overview
8.5.2.2. Financial performance
8.5.2.3. Product benchmarking
8.5.2.4. Strategic initiatives
8.5.3. Abbott
8.5.3.1. Overview
8.5.3.2. Financial performance
8.5.3.3. Product benchmarking
8.5.3.4. Strategic initiatives
8.5.4. Pfizer Inc.
8.5.4.1. Overview
8.5.4.2. Financial performance
8.5.4.3. Product benchmarking
8.5.4.4. Strategic initiatives
8.5.5. Bayer AG
8.5.5.1. Overview
8.5.5.2. Financial performance
8.5.5.3. Product benchmarking
8.5.5.4. Strategic initiatives
8.5.6. Nestlé
8.5.6.1. Overview
8.5.6.2. Financial performance
8.5.6.3. Product benchmarking
8.5.6.4. Strategic initiatives
8.5.7. Reckitt Benckiser Group plc
8.5.7.1. Overview
8.5.7.2. Financial performance
8.5.7.3. Product benchmarking
8.5.7.4. Strategic initiatives
8.5.8. Fresenius Kabi AG
8.5.8.1. Overview
8.5.8.2. Financial performance
8.5.8.3. Product benchmarking
8.5.8.4. Strategic initiatives
8.5.9. Medtrition Middle East, LLC.
8.5.9.1. Overview
8.5.9.2. Financial performance
8.5.9.3. Product benchmarking
8.5.9.4. Strategic initiatives
8.5.10. Dr Nutrition UAE
8.5.10.1. Overview
8.5.10.2. Financial performance
8.5.10.3. Product benchmarking
8.5.10.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us